XTL Biopharmaceuticals Ltd (XTLB) shareholders

XTLBNasdaqPharmaceutical Preparations

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30

$1.60−0.04 (-2.44%)

Close on Nov 13, 2026Market cap $15.14MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions

0.0%

0M of 946M shares

Institutional holders

1 new, 4 sold out

Net institutional buying

-0M

In Q2 2026

Insider trades, 12 months

0 buys · 0 sales

Open-market trades only

Shares held by institutions

Top institutional holders

13F holdings as of Jun 30, 2026

Holder	Shares	% of XTLB	Value	Change	% of portfolio
Rhumbline Advisers	6,228	0.00%	$17.00K	+241	0.00%
GAMMA Investing LLC	1,213	0.00%	$3.31K	−2,175	0.00%
UBS Group AG	125	0.00%	$341	New	0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

Quarter	Holders	Shares held	% of shares	New / added	Reduced / closed	Shares bought	Shares sold
Q2 2026	3	0M	0.0%	1 / 1	1 / 4	0M	0M
Q1 2026	6	0M	0.0%	6 / 0	0 / 0	0M	0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

Fund	Shares	% of XTLB	Value	% of fund	As of
Fidelity Nasdaq Composite Index Fund	2,225	0.00%	$5.34K	0.00%	May 31, 2026
Blackstone Alternative Multi-Strategy Fund	-10	-0.00%	-$27	-0.00%	Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

Name	Role	Shares owned	% of shares	Latest filing
Fain Osnat Hillel	Director	–	–	Mar 23, 2026
Niv Segal	–	–	–	Mar 23, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

Insider	Date	Transaction	Shares	Price	Value	Shares after
Joseph Edelman 10% owner	Nov 19, 2008	Sale	−9,600,000	$0.15	$1.44M	20,580,260
Joseph Edelman 10% owner	Nov 18, 2008	Sale	−29,740	$0.16	$4.76K	3,042,820
Joseph Edelman 10% owner	Nov 18, 2008	Sale	−299,570	$0.15	$44.94K	0
Joseph Edelman 10% owner	Nov 18, 2008	Sale	−24,681,360	$0.14	$3.46M	32,876,710
Joseph Edelman 10% owner	Nov 18, 2008	Sale	−2,696,450	$0.15	$404.47K	30,180,260
Joseph Edelman 10% owner	Nov 18, 2008	Sale	−400,000	$0.16	$64.00K	2,642,820
Joseph Edelman 10% owner	Nov 18, 2008	Sale	−1,943,250	$0.14	$272.06K	699,570
Joseph Edelman 10% owner	Nov 18, 2008	Sale	−400,000	$0.15	$60.00K	299,570
Michael Cho 10% owner	Jun 10, 2008	Buy	+48,960	$3.23	$158.14K	57,558,070
Michael Cho 10% owner	Jun 10, 2008	Buy	+2,040	$3.23	$6.59K	3,072,560
Advisors Llc Perceptive 10% owner	Jun 9, 2008	Buy	+32,260	$3.36	$108.39K	57,509,110
Advisors Llc Perceptive 10% owner	Jun 9, 2008	Buy	+1,340	$3.36	$4.50K	3,070,520
Advisors Llc Perceptive 10% owner	Jun 6, 2008	Buy	+4,000	$3.43	$13.72K	3,069,180
Advisors Llc Perceptive 10% owner	Jun 6, 2008	Buy	+96,000	$3.43	$329.28K	57,476,850
Advisors Llc Perceptive 10% owner	Jun 5, 2008	Buy	+8,000	$3.15	$25.20K	3,065,180
Advisors Llc Perceptive 10% owner	Jun 5, 2008	Buy	+4,000	$3.37	$13.48K	3,057,180
Advisors Llc Perceptive 10% owner	Jun 5, 2008	Buy	+192,000	$3.15	$604.80K	57,380,850
Advisors Llc Perceptive 10% owner	Jun 5, 2008	Buy	+96,000	$3.37	$323.52K	57,188,850
Life Sciences Master Fund Ltd Perceptive 10% owner	Jun 4, 2008	Buy	+24,000	$2.99	$71.76K	57,092,850
Life Sciences Master Fund Ltd Perceptive 10% owner	Jun 4, 2008	Buy	+1,000	$2.99	$2.99K	3,053,180
Life Sciences Master Fund Ltd Perceptive 10% owner	Jun 3, 2008	Buy	+16,040	$3.03	$48.60K	3,052,180
Life Sciences Master Fund Ltd Perceptive 10% owner	Jun 3, 2008	Buy	+384,690	$3.03	$1.17M	57,068,850
Advisors Llc Perceptive 10% owner	May 2, 2008	Buy	+48,000	$3.88	$186.24K	56,683,890
Advisors Llc Perceptive 10% owner	May 2, 2008	Buy	+2,000	$3.88	$7.76K	3,036,140
Advisors Llc Perceptive 10% owner	May 1, 2008	Buy	+100,800	$3.75	$378.00K	56,635,890
Advisors Llc Perceptive 10% owner	May 1, 2008	Buy	+4,200	$3.75	$15.75K	3,034,140
Life Sciences Master Fund Ltd Perceptive 10% owner	Apr 30, 2008	Buy	+5,130	$3.74	$19.19K	3,029,940
Life Sciences Master Fund Ltd Perceptive 10% owner	Apr 30, 2008	Buy	+123,240	$3.74	$460.92K	56,535,090
Life Sciences Master Fund Ltd Perceptive 10% owner	Apr 29, 2008	Buy	+9,160	$3.54	$32.43K	3,024,810
Life Sciences Master Fund Ltd Perceptive 10% owner	Apr 29, 2008	Buy	+220,080	$3.54	$779.08K	56,441,850
Joseph Edelman 10% owner	Apr 10, 2008	Buy	+10,000	$3.56	$35.60K	3,015,650
Joseph Edelman 10% owner	Apr 10, 2008	Buy	+90,000	$3.58	$322.20K	56,191,770
Advisors Llc Perceptive 10% owner	Apr 1, 2008	Buy	+190,950	$3.16	$603.40K	56,101,770
Advisors Llc Perceptive 10% owner	Apr 1, 2008	Buy	+90,000	$3.16	$284.40K	55,910,820
Advisors Llc Perceptive 10% owner	Apr 1, 2008	Buy	+10,050	$3.16	$31.76K	2,995,650
Advisors Llc Perceptive 10% owner	Apr 1, 2008	Buy	+10,000	$3.16	$31.60K	3,005,650
Scott Bradley 10% owner	Mar 28, 2008	Buy	+1,250	$2.90	$3.63K	2,985,600
Scott Bradley 10% owner	Mar 28, 2008	Buy	+23,750	$2.90	$68.88K	55,820,820
Scott Bradley 10% owner	Mar 18, 2008	Buy	+156,350	$3.12	$487.81K	55,797,070
Scott Bradley 10% owner	Mar 18, 2008	Buy	+6,650	$3.12	$20.75K	2,984,350
Scott Bradley 10% owner	Mar 14, 2008	Buy	+188,000	$3.32	$624.16K	55,640,720
Scott Bradley 10% owner	Mar 14, 2008	Buy	+247,220	$3.33	$823.24K	55,452,720
Scott Bradley 10% owner	Mar 14, 2008	Buy	+12,000	$3.32	$39.84K	2,977,700
Scott Bradley 10% owner	Mar 14, 2008	Buy	+15,780	$3.33	$52.55K	2,965,700
Scott Bradley 10% owner	Mar 13, 2008	Buy	+8,820	$3.38	$29.81K	2,943,920
Scott Bradley 10% owner	Mar 13, 2008	Buy	+6,000	$3.37	$20.22K	2,949,920
Life Sciences Master Fund Ltd Perceptive 10% owner	Mar 13, 2008	Buy	+94,000	$3.37	$316.78K	55,205,500
Life Sciences Master Fund Ltd Perceptive 10% owner	Mar 13, 2008	Buy	+138,180	$3.38	$467.05K	55,111,500
Scott Bradley 10% owner	Mar 12, 2008	Buy	+9,000	$3.37	$30.33K	2,935,100
Scott Bradley 10% owner	Mar 12, 2008	Buy	+17,400	$3.35	$58.29K	2,926,100
Life Sciences Master Fund Ltd Perceptive 10% owner	Mar 12, 2008	Buy	+141,000	$3.37	$475.17K	54,700,720
Life Sciences Master Fund Ltd Perceptive 10% owner	Mar 12, 2008	Buy	+272,600	$3.35	$913.21K	54,973,320
Life Sciences Master Fund Ltd Perceptive 10% owner	Mar 11, 2008	Buy	+30,000	$3.31	$99.30K	2,896,800
Life Sciences Master Fund Ltd Perceptive 10% owner	Mar 11, 2008	Buy	+11,900	$3.30	$39.27K	2,908,700
Life Sciences Master Fund Ltd Perceptive 10% owner	Mar 11, 2008	Buy	+470,000	$3.31	$1.56M	54,452,620
Life Sciences Master Fund Ltd Perceptive 10% owner	Mar 11, 2008	Buy	+107,100	$3.30	$353.43K	54,559,720
Life Sciences Master Fund Ltd Perceptive 10% owner	Mar 10, 2008	Buy	+470,000	$3.15	$1.48M	53,587,820
Life Sciences Master Fund Ltd Perceptive 10% owner	Mar 10, 2008	Buy	+25,200	$3.28	$82.66K	2,866,800
Life Sciences Master Fund Ltd Perceptive 10% owner	Mar 10, 2008	Buy	+30,000	$3.15	$94.50K	2,841,600
Life Sciences Master Fund Ltd Perceptive 10% owner	Mar 10, 2008	Buy	+30,000	$3.25	$97.50K	2,811,600

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding

–

0M shares short

Days to cover

1.1

At 0M shares a day

Change since last report

+2.2%

From 0M shares

Short volume, 20 days

27.9%

Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of XTL Biopharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,347 shares on Aug 31, 2026 over the last 90 days.

See a number that looks wrong?